# Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty

> **NCT04785625** · PHASE3 · COMPLETED · sponsor: **Innocoll** · enrollment: 366 (actual)

## Conditions studied

- Pain, Postoperative
- Abdominoplasty

## Interventions

- **COMBINATION_PRODUCT:** Bupivacaine Hydrochloride
- **COMBINATION_PRODUCT:** Placebo collagen-matrix implant

## Key facts

- **NCT ID:** NCT04785625
- **Lead sponsor:** Innocoll
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-29
- **Primary completion:** 2021-10-27
- **Final completion:** 2021-10-27
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2022-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785625, "Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04785625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*